Lyssikatos Joseph P plan to sell securities of Enliven Therapeutics, Inc. under Form 144

Lyssikatos Joseph P filed Form 144 to notify SEC of plan to sell 5000 units of Enliven Therapeutics, Inc. securities around 2025-12-19, with aggregate market value of $83,400.00. The total outstanding units is 59000000.0. The amount planned to be sold represents 0.01% of total outstanding units; Recent transactions in past 3 months include: On 11/19/2025, sold 12500 units for $279155.45; On 09/23/2025, sold 1500 units for $30045.00; On 09/26/2025, sold 4000 units for $81005.00; On 10/20/2025, sold 12500 units for $276024.53;